Cargando…
Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B
An effective and inexpensive protocol for producing cytochalasins A and B is being disclosed to propose a viable method by which to examine the in vivo antineoplastic activity of these congeners in preclinical tumor-bearing mammalian models. In addition, we determine the maximum tolerated doses of c...
Autores principales: | Trendowski, Matthew, Zoino, Joseph N., Christen, Timothy D., Acquafondata, Christopher, Fondy, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562975/ https://www.ncbi.nlm.nih.gov/pubmed/26310377 http://dx.doi.org/10.1016/j.tranon.2015.06.003 |
Ejemplares similares
-
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
por: Trendowski, Matthew
Publicado: (2015)